PetMed Express's ROE % for the quarter that ended in Mar. 2026 was -52.65%. PetMed Express's PB Ratio for the quarter that ended in Mar. 2026 was 1.69.
PetMed Express's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -31.15%.
PetMed Express ROE % Adjusted to Book Value Related Terms
PetMed Express ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for PetMed Express's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PETS vs BHIC, SHFH, SCNX: ROE % Adjusted to Book Value Comparison
For the Pharmaceutical Retailers subindustry, PetMed Express's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where PetMed Express's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -31.15% mean?
PetMed Express (PETS) has a ROE % Adjusted to Book Value of -31.15% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PetMed Express and its competitors.
Is PetMed Express' ROE % Adjusted to Book Value too high?
PetMed Express' current ROE % Adjusted to Book Value is -31.15%. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' ROE % Adjusted to Book Value compare to BHIC and SHFH?
PetMed Express' ROE % Adjusted to Book Value of -31.15% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PetMed Express and its competitors. PetMed Express's current ROE % Adjusted to Book Value is -31.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.87, compared to a current price of $1.76 — trading 38.7% below its estimated fair value. The current ROE % Adjusted to Book Value is -31.15%. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For PetMed Express (PETS), the current ROE % Adjusted to Book Value is -31.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $1.76 is trading 38.7% below its estimated GF Value™ of $2.87.
GuruFocus considers PetMed Express to be Possible Value Trap.
Key valuation signals for PETS:
ROE % Adjusted to Book Value: -31.15%
GF Value™: $2.87 vs. price of $1.76 (38.7% below fair value)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 
